Cargando…

Multisession radiosurgery for intracranial meningioma treatment: study protocol of a single arm, monocenter, prospective trial

BACKGROUND: Single session radiosurgery represents a widely accepted treatment for intracranial meningiomas. However, this approach could involve a high risk of treatment-related complications when applied to large volume lesions. In these cases and for those not suitable for surgical resection, rad...

Descripción completa

Detalles Bibliográficos
Autores principales: Pinzi, V., Marchetti, M., De Martin, E., Cuccarini, V., Tramacere, I., Ghielmetti, F., Fumagalli, M. L., Iezzoni, C., Fariselli, L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6993396/
https://www.ncbi.nlm.nih.gov/pubmed/32000819
http://dx.doi.org/10.1186/s13014-020-1478-7
_version_ 1783493024069713920
author Pinzi, V.
Marchetti, M.
De Martin, E.
Cuccarini, V.
Tramacere, I.
Ghielmetti, F.
Fumagalli, M. L.
Iezzoni, C.
Fariselli, L.
author_facet Pinzi, V.
Marchetti, M.
De Martin, E.
Cuccarini, V.
Tramacere, I.
Ghielmetti, F.
Fumagalli, M. L.
Iezzoni, C.
Fariselli, L.
author_sort Pinzi, V.
collection PubMed
description BACKGROUND: Single session radiosurgery represents a widely accepted treatment for intracranial meningiomas. However, this approach could involve a high risk of treatment-related complications when applied to large volume lesions. In these cases and for those not suitable for surgical resection, radiosurgery in multisession setting could represents a viable option. The literature results are reassuring in terms of correlated adverse events as well as in terms of tumor control. However, no prospective long-term results are available. In this scenario, we design a prospective monocentric phase II study, in order to verify the safety of a multisession radiosurgery schedule delivering 25 Gy in 5 daily fractions. METHODS: Patients diagnosed with large and/or near to critical structures, intracranial meningiomas have been treated by means of multisession radiosurgery in both exclusive and postoperative settings. The primary study aim is safety that has been being prospectively scored based on international scales, including NCI Common Toxicity criteria, version 4.03, Barrow Neurological Institute pain intensity score, Barrow Neurological Institute facial numbness score and House-Brackmann Facial Nerve Grading System for qualitative analysis. Secondary aim is treatment efficacy in terms of local control that has been being assessed on volumetric analysis. DISCUSSION: This is the first prospective phase II trial on multisession radiosurgery for large and/or near to critical structures intracranial meningiomas. If positive results will be found, this study could represent the starting point for a phase III trial exploring the role of multisession radiosurgery in the exclusive and postoperative radiation therapy treatment of intracranial meningiomas. TRIAL REGISTRATION: Trial registration: clinicaltrials.gov platform (Multisession Radiosurgery in Large Meningiomas –MuRaLM- identifier NCT02974127). Registered: November 28, 2016. Retrospectively registered, https://clinicaltrials.gov/ct2/show/NCT02974127?term=radiosurgery&cond=Intracranial+Meningioma&draw=2&rank=1
format Online
Article
Text
id pubmed-6993396
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-69933962020-02-04 Multisession radiosurgery for intracranial meningioma treatment: study protocol of a single arm, monocenter, prospective trial Pinzi, V. Marchetti, M. De Martin, E. Cuccarini, V. Tramacere, I. Ghielmetti, F. Fumagalli, M. L. Iezzoni, C. Fariselli, L. Radiat Oncol Study Protocol BACKGROUND: Single session radiosurgery represents a widely accepted treatment for intracranial meningiomas. However, this approach could involve a high risk of treatment-related complications when applied to large volume lesions. In these cases and for those not suitable for surgical resection, radiosurgery in multisession setting could represents a viable option. The literature results are reassuring in terms of correlated adverse events as well as in terms of tumor control. However, no prospective long-term results are available. In this scenario, we design a prospective monocentric phase II study, in order to verify the safety of a multisession radiosurgery schedule delivering 25 Gy in 5 daily fractions. METHODS: Patients diagnosed with large and/or near to critical structures, intracranial meningiomas have been treated by means of multisession radiosurgery in both exclusive and postoperative settings. The primary study aim is safety that has been being prospectively scored based on international scales, including NCI Common Toxicity criteria, version 4.03, Barrow Neurological Institute pain intensity score, Barrow Neurological Institute facial numbness score and House-Brackmann Facial Nerve Grading System for qualitative analysis. Secondary aim is treatment efficacy in terms of local control that has been being assessed on volumetric analysis. DISCUSSION: This is the first prospective phase II trial on multisession radiosurgery for large and/or near to critical structures intracranial meningiomas. If positive results will be found, this study could represent the starting point for a phase III trial exploring the role of multisession radiosurgery in the exclusive and postoperative radiation therapy treatment of intracranial meningiomas. TRIAL REGISTRATION: Trial registration: clinicaltrials.gov platform (Multisession Radiosurgery in Large Meningiomas –MuRaLM- identifier NCT02974127). Registered: November 28, 2016. Retrospectively registered, https://clinicaltrials.gov/ct2/show/NCT02974127?term=radiosurgery&cond=Intracranial+Meningioma&draw=2&rank=1 BioMed Central 2020-01-30 /pmc/articles/PMC6993396/ /pubmed/32000819 http://dx.doi.org/10.1186/s13014-020-1478-7 Text en © The Author(s). 2020 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Study Protocol
Pinzi, V.
Marchetti, M.
De Martin, E.
Cuccarini, V.
Tramacere, I.
Ghielmetti, F.
Fumagalli, M. L.
Iezzoni, C.
Fariselli, L.
Multisession radiosurgery for intracranial meningioma treatment: study protocol of a single arm, monocenter, prospective trial
title Multisession radiosurgery for intracranial meningioma treatment: study protocol of a single arm, monocenter, prospective trial
title_full Multisession radiosurgery for intracranial meningioma treatment: study protocol of a single arm, monocenter, prospective trial
title_fullStr Multisession radiosurgery for intracranial meningioma treatment: study protocol of a single arm, monocenter, prospective trial
title_full_unstemmed Multisession radiosurgery for intracranial meningioma treatment: study protocol of a single arm, monocenter, prospective trial
title_short Multisession radiosurgery for intracranial meningioma treatment: study protocol of a single arm, monocenter, prospective trial
title_sort multisession radiosurgery for intracranial meningioma treatment: study protocol of a single arm, monocenter, prospective trial
topic Study Protocol
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6993396/
https://www.ncbi.nlm.nih.gov/pubmed/32000819
http://dx.doi.org/10.1186/s13014-020-1478-7
work_keys_str_mv AT pinziv multisessionradiosurgeryforintracranialmeningiomatreatmentstudyprotocolofasinglearmmonocenterprospectivetrial
AT marchettim multisessionradiosurgeryforintracranialmeningiomatreatmentstudyprotocolofasinglearmmonocenterprospectivetrial
AT demartine multisessionradiosurgeryforintracranialmeningiomatreatmentstudyprotocolofasinglearmmonocenterprospectivetrial
AT cuccariniv multisessionradiosurgeryforintracranialmeningiomatreatmentstudyprotocolofasinglearmmonocenterprospectivetrial
AT tramacerei multisessionradiosurgeryforintracranialmeningiomatreatmentstudyprotocolofasinglearmmonocenterprospectivetrial
AT ghielmettif multisessionradiosurgeryforintracranialmeningiomatreatmentstudyprotocolofasinglearmmonocenterprospectivetrial
AT fumagalliml multisessionradiosurgeryforintracranialmeningiomatreatmentstudyprotocolofasinglearmmonocenterprospectivetrial
AT iezzonic multisessionradiosurgeryforintracranialmeningiomatreatmentstudyprotocolofasinglearmmonocenterprospectivetrial
AT farisellil multisessionradiosurgeryforintracranialmeningiomatreatmentstudyprotocolofasinglearmmonocenterprospectivetrial